An affordable new BRCA gene test has hit the market, but who should take it? — -- A new genetic testing kit that hits the market today is the most affordable, and arguably one of the simplest, ...

It might feel like your world stops after receiving a diagnosis of breast or ovarian cancer. Even in that mental and emotional fog, there are several next steps to consider. Coming up with a treatment ...

Strangely, I felt calm and prepared. I knew catching it early was key, and I knew about the range of treatment options ...

We tend to think of BRCA genetic mutations as a major risk for breast cancer—and they are. But these mutations—present on genes that can normally help suppress tumor activity via producing proteins ...

In an effort to help women wherever possible, health professionals with the United States Preventative Services Task Force announced Wednesday an expansion of the organization's screening ...

Researchers have found that women who are diagnosed with breast cancer before the age of 55 and carry an inherited mutation in the breast cancer susceptibility genes BRCA1 or BRCA2 ...

Since then, of course, we have a lot more understanding about the gene (technically two: BRCA1 and BRCA2) and how a mutation of it can majorly affect a person's risk of cancer. Companies such as ...

According to the Mayo Clinic, the BRCA test is a blood test that uses DNA analysis to identify harmful changes in one of the two breast cancer susceptibility genes (BRCA1 and BRCA2). Those who have ...

Women who knew their BRCA+ status were diagnosed with earlier stage breast cancer, needed less chemotherapy, less extensive surgery, and had greater overall 5-year survival (98 percent vs. 74 percent) ...

More than 14,000 women learn they have ovarian cancer each year, and despite recent advances in the treatment of the disease, the prognosis remains discouraging. For newly diagnosed patients, fewer ...

Adding olaparib to maintenance therapy with bevacizumab was associated with significantly longer survival for patients with ovarian cancer whose tumors have a BRCA-like genomic profile, but not among ...

Patients with germline BRCA mutations who were diagnosed with breast cancer at or before age 40 and who underwent a bilateral risk-reducing mastectomy (RRM) and/or a risk-reducing ...